Silex Systems Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Silex Systems (ASX:SLX) Full Year 2024 Results
Key Financial Results
- Revenue: AU$17.2m (up 78% from FY 2023).
- Net loss: AU$22.7m (loss widened by 31% from FY 2023).
- AU$0.096 loss per share (further deteriorated from AU$0.081 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Silex Systems Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates significantly. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is expected to fall by 75% p.a. on average during the next 3 years compared to a 3.1% decline forecast for the Machinery industry in Australia.
Performance of the Australian Machinery industry.
The company's shares are down 3.7% from a week ago.
Risk Analysis
Be aware that Silex Systems is showing 1 warning sign in our investment analysis that you should know about...
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:SLX
Silex Systems
A technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom.
Flawless balance sheet with limited growth.